Norgestomet, or norgestamet, sold under the brand name Syncro-Mate B and Crestar, is a progestin medication which is used in veterinary medicine to control estrus and ovulation in cattle.[1][2]
Clinical data | |
---|---|
Trade names | Syncro-Mate B, Crestar |
Other names | Norgestamet; SC-21009; 11β-Methyl-17α-acetoxy-19-norprogesterone; 17α-Hydroxy-11β-methyl-19-norpregn-4-ene-3,20-dione acetate |
Drug class | Progestogen; Progestin; Progestogen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.042.359 |
Chemical and physical data | |
Formula | C23H32O4 |
Molar mass | 372.505 g·mol−1 |
3D model (JSmol) | |
| |
|
Uses
Veterinary
Norgestomet is used in veterinary medicine.
Pharmacology
Pharmacodynamics
Norgestomet is a progestogen. In addition to the progesterone receptor, it possesses weak (micromolar) affinity for the glucocorticoid receptor.[3]
Chemistry
Norgestomet, also known as 11β-methyl-17α-acetoxy-19-norprogesterone or as 17α-hydroxy-11β-methyl-19-norpregn-4-ene-3,20-dione acetate, is a synthetic norpregnane steroid and a derivative of progesterone.[1][4]
History
Norgestomet was developed and introduced for veterinary use in the mid-1970s.[5]
Society and culture
Generic names
Norgestomet is the generic name of the drug and its INN , USAN , and BAN .[1][4] It also known as norgestamet and is known by its developmental code name SC-21009.[1][4][6]
Brand names
Norgestomet is marketed under the brand names Syncro-Mate B and Crestar.[1][4]